NCT00028340View on ClinicalTrials.gov

High-Risk Breast Duct Epithelium

CompletedOBSERVATIONAL

Enrollment

156

Participants

Timeline

Start Date

February 20, 2003

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions

Breast Cancer

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00028340 - High-Risk Breast Duct Epithelium | Biotech Hunter | Biotech Hunter